Global GABA (?-aminobutyric acid) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch＇s in-depth investigation and research, the global GABA (γ-aminobutyric acid) market size will reach 153.38 Million USD in 2025 and is projected to reach 260.66 Million USD by 2032, with a CAGR of 7.87% (2025-2032). Notably, the China GABA (γ-aminobutyric acid) market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be  Million USD, representing approximately  % of the global market share.

Research Summary

Gamma-aminobutyric acid, or GABA, is a neurotransmitter in the brain that plays a crucial role in regulating neuronal excitability throughout the nervous system. As an inhibitory neurotransmitter, GABA works to reduce the activity of neurons, helping to balance and control brain activity. It achieves this by binding to specific receptors, known as GABA receptors, on the surface of neurons, which leads to the opening of ion channels that decrease the likelihood of an action potential, or electrical signal, being generated in the postsynaptic neuron. GABA is involved in various physiological processes, including motor control, cognition, and the regulation of anxiety. Imbalances in GABA levels have been linked to conditions such as anxiety disorders, epilepsy, and insomnia. GABAergic drugs, such as benzodiazepines and barbiturates, are used clinically to modulate GABA activity and treat conditions such as anxiety, seizures, and sleep disorders.

The major global  manufacturers of GABA (γ-aminobutyric acid) include Pharma Foods International, Kyowa Hakko, Sekisui Chemical, Zhejiang YiWan Biolabs, Shanghai Richen, Guangdong Luckerkong Biotech, Tianjin Shijitianlong Biotech, Ningxiang Jiayuan Biology Technology, Zhejiang Tianrui Chemical, Taizhou Xinyou Pharmaceutical & Chemical, Bloomage Freda Biopharm, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of GABA (γ-aminobutyric acid). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global GABA (γ-aminobutyric acid) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the GABA (γ-aminobutyric acid) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of GABA (γ-aminobutyric acid) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of GABA (γ-aminobutyric acid) Include:

Pharma Foods International

Kyowa Hakko

Sekisui Chemical

Zhejiang YiWan Biolabs

Shanghai Richen

Guangdong Luckerkong Biotech

Tianjin Shijitianlong Biotech

Ningxiang Jiayuan Biology Technology

Zhejiang Tianrui Chemical

Taizhou Xinyou Pharmaceutical & Chemical

Bloomage Freda Biopharm

GABA (γ-aminobutyric acid) Product Segment Include:

Microbial Fermentation (Food Grade)

Microbial Fermentation (Feed Grade)

Chemical Synthesis

GABA (γ-aminobutyric acid) Product Application Include:

Food and Pharmaceutical

Animal Feed

Plant Growth Promoter

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global GABA (γ-aminobutyric acid) Capacity and Production Analysis

Chapter 3: Global GABA (γ-aminobutyric acid) Industry PESTEL Analysis

Chapter 4: Global GABA (γ-aminobutyric acid) Industry Porter's Five Forces Analysis

Chapter 5: Global GABA (γ-aminobutyric acid) Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 6: Global GABA (γ-aminobutyric acid) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 7: Global GABA (γ-aminobutyric acid) Sales, Revenue, Price and Forecast by Product Type

Chapter 8: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 9: Industrial Chain Analysis, GABA (γ-aminobutyric acid) Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 10: Research Findings and Conclusion

Chapter 11: Methodology and Data Sources Show more